PETER REILLY: Open Payments
NPI 1033122098 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 13 payments from 6 companies in 2025. Trend: 2023 $1,095 · 2024 $556 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 3 | $138 |
| Lilly USA, LLC | 1 | $123 |
| ABBVIE INC. | 1 | $111 |
| PFIZER INC. | 4 | $93 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $42 |
| LEO Pharma Inc. | 2 | $32 |
Products named: NEMLUVIO, EBGLYSS, SKYRIZI, CIBINQO, VALCHLOR, ADBRY.
Industry payments across RI — which companies pay providers there.
